We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Talkspace
TALK
$873M
| $14.7K | ﹤0.01% |
11,602
| – | – |
|
|
BZUN
3502
Baozun
BZUN
$170M
| $14.4K | ﹤0.01% |
+3,603
| New | +$16.1K |
|
3503
AN2 Therapeutics
ANTX
$220M
| $14.3K | ﹤0.01% |
1,677
-10,033
| -86% | -$72.1K |
|
|
DADA
3504
DELISTED
Dada Nexus
DADA
| $14.2K | ﹤0.01% |
+2,680
| New | +$16.2K |
|
|
NNDM
3505
Nano Dimension
NNDM
$335M
| $14.1K | ﹤0.01% |
+4,875
| New | +$12.1K |
|
3506
The RealReal
REAL
$1.65B
| $14.1K | ﹤0.01% |
6,341
-180,689
| -97% | -$247K |
|
|
ZOM
3507
DELISTED
Zomedica Corp.
ZOM
| $14K | ﹤0.01% |
69,911
| – | – |
|
|
KNTE
3508
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $13.9K | ﹤0.01% |
4,600
-47,773
| -91% | -$184K |
|
|
CRT
3509
Cross Timbers Royalty Trust
CRT
$60.7M
| $13.9K | ﹤0.01% |
+630
| New | +$13.5K |
|
3510
Bioventus
BVS
$1.17B
| $13.8K | ﹤0.01% |
4,776
-43,000
| -90% | -$82.5K |
|
3511
The Honest Company
HNST
$610M
| $13.7K | ﹤0.01% |
8,145
-91,994
| -92% | -$157K |
|
3512
Universal Electronics
UEIC
$73.5M
| $13.6K | ﹤0.01% |
1,417
-17,813
| -93% | -$165K |
|
3513
TaskUs
TASK
$701M
| $13.5K | ﹤0.01% |
+1,195
| New | +$14.5K |
|
3514
Twin Disc
TWIN
$343M
| $13.5K | ﹤0.01% |
+1,200
| New | +$13.2K |
|
3515
ReNew
RNW
$2.27B
| $13.5K | ﹤0.01% |
+2,464
| New | +$13.5K |
|
|
CMRX
3516
DELISTED
Chimerix, Inc.
CMRX
| $13.5K | ﹤0.01% |
11,135
-105,030
| -90% | -$133K |
|
3517
Telos
TLS
$352M
| $13.4K | ﹤0.01% |
5,218
-63,250
| -92% | -$150K |
|
|
HERE
3518
Here Group Ltd
HERE
$101M
| $13.4K | ﹤0.01% |
+1,590
| New | +$15.8K |
|
3519
Televisa
TV
$1.5B
| $13.1K | ﹤0.01% |
+2,562
| New | +$12.9K |
|
3520
Aemetis
AMTX
$113M
| $13.1K | ﹤0.01% |
1,781
-47,376
| -96% | -$180K |
|
|
MTL
3521
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $13.1K | ﹤0.01% |
+5,800
| New | +$13.1K |
|
3522
BioVie
BIVI
$7.77M
| $13K | ﹤0.01% |
+30
| New | +$20.2K |
|
3523
BioNTech
BNTX
$23.1B
| $13K | ﹤0.01% |
+120
| New | +$13.5K |
|
|
WIMI
3524
WiMi Hologram Cloud
WIMI
$25.4M
| $12.9K | ﹤0.01% |
+1,177
| New | +$11.9K |
|
|
YI
3525
111 Inc
YI
$33.3M
| $12.9K | ﹤0.01% |
+525
| New | +$14.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.